MiR-145-5p alleviates hypoxia/reoxygenation-induced cardiac microvascular endothelial cell injury in coronary heart disease by inhibiting Smad4 expression
MiR-145-5p alleviates hypoxia/reoxygenation-induced cardiac microvascular endothelial cell injury in coronary heart disease by inhibiting Smad4 expression
复制标题
DOI:
10.26355/eurrev_202005_21192
复制
发表时间:
2020-05-01
影响因子:
3.3
通讯作者:
Xue, A-G
中科院分区:
文献类型:
--
作者:
Li, L-L;Mao, C-D;Xue, A-G
OBJECTIVE: To investigate the effects and mechanism of miR-145-5p on hypoxia/reoxygenation (H/R)-induced cardiac microvascular endothelial cell (CMEC) injury in coronary heart disease (CHD).PATIENTS AND METHODS: Patients with CHD (n=96) and healthy volunteers (n= 96) were enrolled, and H/R injury model of CMECs was established. The expression of miR-145-5p and mothers against decapentaplegic homolog 4 (Smad4) mRNA in cells was quantified with reverse transcription polymerase chain reaction (RT-PCR). Then, miR-145-5p mimics and Smad4 inhibitor were transfected into CMECs. Cell counting kit-8 (CCK-8) was employed for proliferation detection, flow cytometry for apoptosis detection, and Western Blot for measuring the expression of apoptosis-related proteins and Smad4 protein.RESULTS: The expression of serum miR-1455p in patients with CHD was significantly lower than that in healthy individuals. The area under the curve (AUC) of miR-145-5p in diagnosing CHD was 0.894, and the expression of miR-145-5p was negatively correlated with that of Smad4 (p